Literature DB >> 11313499

Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 A resolution.

A L Gnatt1, P Cramer, J Fu, D A Bushnell, R D Kornberg.   

Abstract

The crystal structure of RNA polymerase II in the act of transcription was determined at 3.3 A resolution. Duplex DNA is seen entering the main cleft of the enzyme and unwinding before the active site. Nine base pairs of DNA-RNA hybrid extend from the active center at nearly right angles to the entering DNA, with the 3' end of the RNA in the nucleotide addition site. The 3' end is positioned above a pore, through which nucleotides may enter and through which RNA may be extruded during back-tracking. The 5'-most residue of the RNA is close to the point of entry to an exit groove. Changes in protein structure between the transcribing complex and free enzyme include closure of a clamp over the DNA and RNA and ordering of a series of "switches" at the base of the clamp to create a binding site complementary to the DNA-RNA hybrid. Protein-nucleic acid contacts help explain DNA and RNA strand separation, the specificity of RNA synthesis, "abortive cycling" during transcription initiation, and RNA and DNA translocation during transcription elongation.

Mesh:

Substances:

Year:  2001        PMID: 11313499     DOI: 10.1126/science.1059495

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  363 in total

1.  Translocation after synthesis of a four-nucleotide RNA commits RNA polymerase II to promoter escape.

Authors:  Jennifer F Kugel; James A Goodrich
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Structural basis of transcription: alpha-amanitin-RNA polymerase II cocrystal at 2.8 A resolution.

Authors:  David A Bushnell; Patrick Cramer; Roger D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Strong natural pausing by RNA polymerase II within 10 bases of transcription start may result in repeated slippage and reextension of the nascent RNA.

Authors:  Mahadeb Pal; Donal S Luse
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Structure-based analysis of RNA polymerase function: the largest subunit's rudder contributes critically to elongation complex stability and is not involved in the maintenance of RNA-DNA hybrid length.

Authors:  Konstantin Kuznedelov; Nataliya Korzheva; Arkady Mustaev; Konstantin Severinov
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Old dogs and new tricks: meeting on mechanisms of eukaryotic transcription.

Authors:  Elena Ejkova; William P Tansey
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

6.  Marking the start site of RNA polymerase III transcription: the role of constraint, compaction and continuity of the transcribed DNA strand.

Authors:  Anne Grove; Morgan S Adessa; E Peter Geiduschek; George A Kassavetis
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

7.  Mechanism of poly(A) signal transduction to RNA polymerase II in vitro.

Authors:  D P Tran; S J Kim; N J Park; T M Jew; H G Martinson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  RNA polymerase II complexes in the very early phase of transcription are not susceptible to TFIIS-induced exonucleolytic cleavage.

Authors:  Robert Sijbrandi; Ulrike Fiedler; H Th Marc Timmers
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

9.  The initiation-elongation transition: lateral mobility of RNA in RNA polymerase II complexes is greatly reduced at +8/+9 and absent by +23.

Authors:  Mahadeb Pal; Donal S Luse
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

10.  Single molecule analysis of RNA polymerase elongation reveals uniform kinetic behavior.

Authors:  Karen Adelman; Arthur La Porta; Thomas J Santangelo; John T Lis; Jeffrey W Roberts; Michelle D Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.